This is a discussion on TA137: Lymphoma (follicular non-Hodgkin's) - rituximab within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Lymphoma (follicular non-Hodgkin's) - rituximab. It links to the published guidance ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
The summary for the published technology appraisal on Lymphoma (follicular non-Hodgkin's) - rituximab. It links to the published guidance and key documents.
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA65: Non-Hodgkin's lymphoma - rituximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA110: Follicular lymphoma - rituximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| Long-Term Data Confirm Rituximab Plus Chemo in Follicular Lymphoma | industry_news | Other Clinical Pharmacy News | 0 | 07-31-2008 02:22 PM |
| Early Study Finds Increased Non-Hodgkin's Lymphoma in Long-Term Users of Tricyclic Antidepressants | industry_news | Other Clinical Pharmacy News | 0 | 07-29-2008 01:38 PM |
| Pegylated Liposomal Doxorubicin Effective in Hard-To-Treat Cutaneous T-Cell Lymphoma | industry_news | Other Clinical Pharmacy News | 0 | 07-07-2008 03:45 PM |